In contrast, in our cohort, no decrease in CXCR3+ CD4+ T cells was observed in the lung parenchyma, and IPF patients actually exhibited increased CXCR3+ CD4+ T cells in the LLN compared to controls. This evidence concerns the gene CXCR3 and idiopathic pulmonary fibrosis.